Nearly 12 month's ago 13/12, the 80m shares man - Dixon, said they were looking at pre-filled syringes and other devices with improved margins. Now he says they are looking at 2 preclinical possibilities - absolutely meaningless stalling. It appears the matter I raised earlier about ownership is correct.
